(0.25%) 5 560.00 points
(0.01%) 39 553 points
(0.40%) 20 119 points
(0.66%) $82.28
(0.82%) $2.71
(0.00%) $2 336.50
(0.63%) $29.44
(0.45%) $1 010.70
(0.15%) $0.935
(0.44%) $10.67
(0.04%) $0.791
(1.77%) $86.50
2.24% HKD 31.95
Live Chart Being Loaded With Signals
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, the United States, the United Kingdom, and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 444 100 |
Średni wolumen | 133 598 |
Kapitalizacja rynkowa | 14.93B |
EPS | HKD0.580 ( Q1 | 2024-03-31 ) |
Następna data zysków | ( HKD0 ) 2024-08-14 |
Last Dividend | HKD0.441 ( 2023-07-04 ) |
Next Dividend | HKD0 ( N/A ) |
P/E |
16.38 (Sector) 14.27 (Industry) 6.31 |
ATR14 | HKD0.132 (0.42%) |
Wolumen Korelacja
Shanghai Haohai Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Shanghai Haohai Korelacja - Waluta/Towar
Shanghai Haohai Finanse
Annual | 2023 |
Przychody: | HKD2.63B |
Zysk brutto: | HKD1.85B (70.34 %) |
EPS: | HKD2.44 |
FY | 2023 |
Przychody: | HKD2.63B |
Zysk brutto: | HKD1.85B (70.34 %) |
EPS: | HKD2.44 |
FY | 2022 |
Przychody: | HKD2.10B |
Zysk brutto: | HKD1.45B (68.79 %) |
EPS: | HKD1.040 |
FY | 2021 |
Przychody: | HKD1.75B |
Zysk brutto: | HKD1.26B (71.98 %) |
EPS: | HKD2.16 |
Financial Reports:
No articles found.
Shanghai Haohai Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.820 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.441 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.472 | 2016-06-08 |
Last Dividend | HKD0.441 | 2023-07-04 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 8 | -- |
Total Paid Out | HKD4.88 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.42 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.57 | |
Div. Directional Score | 9.47 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
04 Jul 2023 | HKD0.441 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
29 Jul 2022 | HKD0.820 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
15 Jul 2021 | HKD0.606 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
02 Jul 2020 | HKD0.766 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
14 Mar 2019 | HKD0.585 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
19 Jun 2018 | HKD0.612 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
29 Jun 2017 | HKD0.573 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
08 Jun 2016 | HKD0.472 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6868.HK | Ex Dividend Knight | 2023-09-01 | Semi-Annually | 0 | 0.00% | |
1234.HK | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
2628.HK | Ex Dividend Knight | 2023-07-05 | Annually | 0 | 0.00% | |
0807.HK | Ex Dividend Knight | 2023-09-11 | Semi-Annually | 0 | 0.00% | |
1962.HK | Ex Dividend Junior | 2023-09-11 | Annually | 0 | 0.00% | |
0386.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
1443.HK | Ex Dividend Junior | 2023-10-04 | Annually | 0 | 0.00% | |
0046.HK | Ex Dividend Knight | 2023-08-31 | Semi-Annually | 0 | 0.00% | |
3848.HK | Ex Dividend Junior | 2023-07-04 | Annually | 0 | 0.00% | |
0991.HK | Ex Dividend Junior | 2023-06-30 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.162 | 1.500 | 6.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0601 | 1.200 | 8.00 | 9.59 | [0 - 0.3] |
returnOnEquityTTM | 0.0758 | 1.500 | -0.269 | -0.403 | [0.1 - 1] |
payoutRatioTTM | 0.00467 | -1.000 | 9.95 | -9.95 | [0 - 1] |
currentRatioTTM | 5.43 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.43 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.88 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0296 | -1.500 | 9.51 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 52.94 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.37 | 2.00 | 8.88 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.049 | 2.00 | 9.48 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0370 | -1.500 | 9.85 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.698 | 1.000 | 1.699 | 1.699 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.177 | 1.000 | 8.46 | 8.46 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.67 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.371 | 0.800 | -0.859 | -0.687 | [0.5 - 2] |
Total Score | 12.36 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.15 | 1.000 | 8.97 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0758 | 2.50 | -0.173 | -0.403 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.049 | 2.00 | 9.65 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.39 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.37 | 2.00 | 8.88 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.00467 | 1.500 | 9.95 | -9.95 | [0 - 1] |
pegRatioTTM | 0.790 | 1.500 | 8.06 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.213 | 1.000 | 7.18 | 0 | [0.1 - 0.5] |
Total Score | 6.57 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Shanghai Haohai
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, the United States, the United Kingdom, and internationally. It offers ophthalmology products comprising intraocular lens, ophthalmic viscoelastic devices, orthokeratology and phakic refractive lenses, eye drops, injectors, scalpels, etc.; orthopedics products, such as sodium hyaluronate injection and medical chitosan; wound repair products, including recombinant human epidermal growth factor for the treatment of burn wound, residual wound, donor site posttraumatic wound, and fresh or old wound of chronic ulcer; anti-adhesion materials comprising medical sodium hyaluronate gel and medical chitosan; and hemostatic materials, such as collagen sponge and porcine fibrin sealants. The company also provides medical aesthetics products comprising Matrifill, a first-generation HA dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; and radio frequency devices and laser equipment. In addition, it is involved in research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; and investment and trading business. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej